# FDA Inspection 967278 - Prinston Pharmaceutical Inc - April 05, 2016

Source: https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/5fe1627e-8b92-47cd-9437-310a0a8a70e6
Source feed: FDA_Inspections

> FDA Inspection 967278 for Prinston Pharmaceutical Inc on April 05, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 967278
- Company Name: Prinston Pharmaceutical Inc
- Inspection Date: 2016-04-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260044 - 2025-08-26](https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/aa126585-d984-4276-a092-4a42ecfefeb1)
- [FDA Inspection 1260044 - 2025-08-26](https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/5325905e-342f-4328-8f50-e286c07aa6a8)
- [FDA Inspection 808907 - 2012-11-30](https://www.keypedia.com/records/fda_inspections/prinston-pharmaceutical-inc/ae4fc011-4244-4744-a9ab-8bea1d2eb319)

Company: https://www.keypedia.com/companies/prinston-pharmaceutical-inc/72ffd69b-9c04-4962-af92-315100419ae8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c